Logo image of DUOT

DUOS TECHNOLOGIES GROUP INC (DUOT) Stock Fundamental Analysis

NASDAQ:DUOT - Nasdaq - US2660424076 - Common Stock - Currency: USD

7.95  -0.12 (-1.49%)

Fundamental Rating

1

DUOT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. DUOT has a bad profitability rating. Also its financial health evaluation is rather negative. DUOT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DUOT had negative earnings in the past year.
DUOT had a negative operating cash flow in the past year.
DUOT had negative earnings in each of the past 5 years.
In the past 5 years DUOT always reported negative operating cash flow.
DUOT Yearly Net Income VS EBIT VS OCF VS FCFDUOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

DUOT has a Return On Assets of -29.61%. This is in the lower half of the industry: DUOT underperforms 74.11% of its industry peers.
Looking at the Return On Equity, with a value of -195.88%, DUOT is doing worse than 79.79% of the companies in the same industry.
Industry RankSector Rank
ROA -29.61%
ROE -195.88%
ROIC N/A
ROA(3y)-56.91%
ROA(5y)-67.89%
ROE(3y)-284.96%
ROE(5y)-396.89%
ROIC(3y)N/A
ROIC(5y)N/A
DUOT Yearly ROA, ROE, ROICDUOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 15.12%, DUOT is doing worse than 84.40% of the companies in the same industry.
In the last couple of years the Gross Margin of DUOT has declined.
DUOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-32.94%
DUOT Yearly Profit, Operating, Gross MarginsDUOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

DUOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
DUOT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DUOT has been increased compared to 5 years ago.
DUOT has a worse debt/assets ratio than last year.
DUOT Yearly Shares OutstandingDUOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
DUOT Yearly Total Debt VS Total AssetsDUOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

DUOT has an Altman-Z score of -2.06. This is a bad value and indicates that DUOT is not financially healthy and even has some risk of bankruptcy.
DUOT has a worse Altman-Z score (-2.06) than 79.08% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that DUOT is not too dependend on debt financing.
The Debt to Equity ratio of DUOT (0.34) is worse than 61.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z -2.06
ROIC/WACCN/A
WACC10.96%
DUOT Yearly LT Debt VS Equity VS FCFDUOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

DUOT has a Current Ratio of 0.53. This is a bad value and indicates that DUOT is not financially healthy enough and could expect problems in meeting its short term obligations.
DUOT's Current ratio of 0.53 is on the low side compared to the rest of the industry. DUOT is outperformed by 89.36% of its industry peers.
DUOT has a Quick Ratio of 0.53. This is a bad value and indicates that DUOT is not financially healthy enough and could expect problems in meeting its short term obligations.
DUOT has a Quick ratio of 0.50. This is amonst the worse of the industry: DUOT underperforms 89.72% of its industry peers.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.5
DUOT Yearly Current Assets VS Current LiabilitesDUOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.27% over the past year.
The Revenue has grown by 89.27% in the past year. This is a very strong growth!
The Revenue for DUOT have been decreasing by -11.80% on average. This is quite bad
EPS 1Y (TTM)27.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.63%
Revenue 1Y (TTM)89.27%
Revenue growth 3Y-4.12%
Revenue growth 5Y-11.8%
Sales Q2Q%362.51%

3.2 Future

Based on estimates for the next years, DUOT will show a very strong growth in Earnings Per Share. The EPS will grow by 42.19% on average per year.
DUOT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 117.51% yearly.
EPS Next Y62.11%
EPS Next 2Y42.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year228.83%
Revenue Next 2Y117.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DUOT Yearly Revenue VS EstimatesDUOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
DUOT Yearly EPS VS EstimatesDUOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DUOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 259.80, the valuation of DUOT can be described as expensive.
Based on the Price/Forward Earnings ratio, DUOT is valued a bit more expensive than the industry average as 63.12% of the companies are valued more cheaply.
DUOT is valuated expensively when we compare the Price/Forward Earnings ratio to 37.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 259.8
DUOT Price Earnings VS Forward Price EarningsDUOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DUOT Per share dataDUOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as DUOT's earnings are expected to grow with 42.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.19%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DUOT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DUOS TECHNOLOGIES GROUP INC

NASDAQ:DUOT (7/25/2025, 10:33:28 AM)

7.95

-0.12 (-1.49%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-11 2025-08-11
Inst Owners23.45%
Inst Owner Change0%
Ins Owners23.93%
Ins Owner Change0.32%
Market Cap92.62M
Analysts82.5
Price Target12.75 (60.38%)
Short Float %3.07%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.15%
Min EPS beat(2)-36.26%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-8.16%
Min EPS beat(4)-36.26%
Max EPS beat(4)29.41%
EPS beat(8)3
Avg EPS beat(8)-25.98%
EPS beat(12)6
Avg EPS beat(12)-17.78%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-17.5%
Min Revenue beat(2)-47.91%
Max Revenue beat(2)12.9%
Revenue beat(4)3
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-47.91%
Max Revenue beat(4)18.47%
Revenue beat(8)3
Avg Revenue beat(8)-18.79%
Revenue beat(12)5
Avg Revenue beat(12)-13.45%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.7%
PT rev (3m)16.28%
EPS NQ rev (1m)-30.3%
EPS NQ rev (3m)-48.28%
EPS NY rev (1m)-38.67%
EPS NY rev (3m)-36.84%
Revenue NQ rev (1m)-2.94%
Revenue NQ rev (3m)-1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)15.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 259.8
P/S 8.3
P/FCF N/A
P/OCF N/A
P/B 17.98
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.2
EYN/A
EPS(NY)0.03
Fwd EY0.38%
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.96
BVpS0.44
TBVpS-0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.61%
ROE -195.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.12%
FCFM N/A
ROA(3y)-56.91%
ROA(5y)-67.89%
ROE(3y)-284.96%
ROE(5y)-396.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-32.94%
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 84.9%
Cap/Sales 21.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.5
Altman-Z -2.06
F-Score3
WACC10.96%
ROIC/WACCN/A
Cap/Depr(3y)154.97%
Cap/Depr(5y)158.63%
Cap/Sales(3y)14.73%
Cap/Sales(5y)10.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.63%
EPS Next Y62.11%
EPS Next 2Y42.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)89.27%
Revenue growth 3Y-4.12%
Revenue growth 5Y-11.8%
Sales Q2Q%362.51%
Revenue Next Year228.83%
Revenue Next 2Y117.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.7%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.06%
OCF growth 3YN/A
OCF growth 5YN/A